Mary Nantongo

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Venues

ACS infectious diseases

mBio

This page only lists publications with an associated author ORCID identifier.

Publications

Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Mark Plummer, Mary Nantongo, Christopher R Bethel, David C Nguyen, Barry N Kreiswith, Charles L Daley, Kenneth E Remy, Steven M Holland, Robert A Bonomo
Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus . mBio 15 (6) (2024)
Mary Nantongo, David C Nguyen, Christopher R Bethel, Magdalena A Taracila, Qing Li, Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Liem Nguyen, Barry N Kreiswirth, W Henry Boom, Mark S Plummer, Robert A Bonomo
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis . ACS infectious diseases (2024)
Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Mark Plummer, Mary Nantongo, Christopher R Bethel, David C Nguyen, Barry N Kreiswith, Charles L Daley, Kenneth E Remy, Steven M Holland, Robert A Bonomo
Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus . mBio (2024)
Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Mark Plummer, Mary Nantongo, Christopher R Bethel, David C Nguyen, Barry N Kreiswith, Charles L Daley, Kenneth E Remy, Steven M Holland, Robert A Bonomo
Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus . mBio 15 (6) (2024)
Mary Nantongo, David C Nguyen, Christopher R Bethel, Magdalena A Taracila, Qing Li, Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Liem Nguyen, Barry N Kreiswirth, W Henry Boom, Mark S Plummer, Robert A Bonomo
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis . ACS infectious diseases (2024)
Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Mark Plummer, Mary Nantongo, Christopher R Bethel, David C Nguyen, Barry N Kreiswith, Charles L Daley, Kenneth E Remy, Steven M Holland, Robert A Bonomo
Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus . mBio 15 (6) (2024)
Mary Nantongo, David C Nguyen, Christopher R Bethel, Magdalena A Taracila, Qing Li, Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Liem Nguyen, Barry N Kreiswirth, W Henry Boom, Mark S Plummer, Robert A Bonomo
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis . ACS infectious diseases 10 (5) (2024)
Mary Nantongo, David C Nguyen, Christopher R Bethel, Magdalena A Taracila, Qing Li, Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Liem Nguyen, Barry N Kreiswirth, W Henry Boom, Mark S Plummer, Robert A Bonomo
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis . ACS infectious diseases 10 (5) (2024)
Mary Nantongo, David C Nguyen, Christopher R Bethel, Magdalena A Taracila, Qing Li, Khalid M Dousa, Eunjeong Shin, Sebastian G Kurz, Liem Nguyen, Barry N Kreiswirth, W Henry Boom, Mark S Plummer, Robert A Bonomo
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis . ACS infectious diseases 10 (5) (2024)

Mary Nantongo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mary Nantongo